“…4,7 The long term outcomes of patients with NAFLD and NASH have been reported in several studies. 31,[38][39][40][41][42][43][44][45] Their detailed discussion is beyond the scope of this guideline, but their findings can be summarized as follows; (a) patients with NAFLD have increased overall mortality compared to matched control populations, (b) the most common cause of death in patients with NAFLD, NAFL and NASH is cardiovascular disease, and (c) patients with NASH (but not NAFL) have an increased liver-related mortality rate.…”